RU2004113712A - METHOD FOR TREATING HYPOCALCY, OSTEOPOROSIS, FRACTURES - Google Patents

METHOD FOR TREATING HYPOCALCY, OSTEOPOROSIS, FRACTURES Download PDF

Info

Publication number
RU2004113712A
RU2004113712A RU2004113712/14A RU2004113712A RU2004113712A RU 2004113712 A RU2004113712 A RU 2004113712A RU 2004113712/14 A RU2004113712/14 A RU 2004113712/14A RU 2004113712 A RU2004113712 A RU 2004113712A RU 2004113712 A RU2004113712 A RU 2004113712A
Authority
RU
Russia
Prior art keywords
osteoporosis
fractures
hypocalcy
treating
crystalline
Prior art date
Application number
RU2004113712/14A
Other languages
Russian (ru)
Other versions
RU2268053C1 (en
Inventor
Григорий Николаевич Коныгин (RU)
Григорий Николаевич Коныгин
Николай Сергеевич Стрелков (RU)
Николай Сергеевич Стрелков
Евгений Павлович Тюлькин (RU)
Евгений Павлович Тюлькин
Виктор Владимирович Поздеев (RU)
Виктор Владимирович Поздеев
Пётр Николаевич Максимов (RU)
Пётр Николаевич Максимов
Александр Николаевич Филиппов (RU)
Александр Николаевич Филиппов
Сергей Борисович Шишкин (RU)
Сергей Борисович Шишкин
Фаат Залалутдинович Гильмутдинов (RU)
Фаат Залалутдинович Гильмутдинов
Геннадий Алексеевич Дорофеев (RU)
Геннадий Алексеевич Дорофеев
Евгений Петрович Елсуков (RU)
Евгений Петрович Елсуков
Original Assignee
Григорий Николаевич Коныгин (RU)
Григорий Николаевич Коныгин
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Григорий Николаевич Коныгин (RU), Григорий Николаевич Коныгин filed Critical Григорий Николаевич Коныгин (RU)
Priority to RU2004113712/14A priority Critical patent/RU2268053C1/en
Priority to PCT/RU2005/000202 priority patent/WO2005105118A1/en
Publication of RU2004113712A publication Critical patent/RU2004113712A/en
Application granted granted Critical
Publication of RU2268053C1 publication Critical patent/RU2268053C1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (2)

1. Способ лечения гипокальциемий, остеопорозов, переломов, включающий применение препаратов кальция, отличающийся тем, что официнальные твердые дисперсные кристаллические или таблетированные кристаллические лекарственные препараты кальция предварительно измельчают до аморфного состояния, применяют перорально, 2-4 раза в день, дозами по 0,5-1,0 г, курсами по 15-20 дней с перерывами в применении 1-2 недели, до полного излечения.1. A method for the treatment of hypocalcemia, osteoporosis, fractures, including the use of calcium preparations, characterized in that the officinal solid dispersed crystalline or crystalline crystalline tablets of calcium are pre-crushed to an amorphous state, used orally, 2-4 times a day, in doses of 0.5 -1.0 g, courses of 15-20 days with interruptions in use for 1-2 weeks, until complete cure. 2. Способ лечения по п.1, отличающийся тем, что препараты кальция измельчают до размера частиц не превышающих 1 мкм.2. The treatment method according to claim 1, characterized in that the calcium preparations are ground to a particle size not exceeding 1 μm.
RU2004113712/14A 2004-05-05 2004-05-05 Method for treating hypocalcemia, osteoporosis , fractures RU2268053C1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
RU2004113712/14A RU2268053C1 (en) 2004-05-05 2004-05-05 Method for treating hypocalcemia, osteoporosis , fractures
PCT/RU2005/000202 WO2005105118A1 (en) 2004-05-05 2005-04-18 Method for treating hypocalcemias, osteoporosis and fractures

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2004113712/14A RU2268053C1 (en) 2004-05-05 2004-05-05 Method for treating hypocalcemia, osteoporosis , fractures

Publications (2)

Publication Number Publication Date
RU2004113712A true RU2004113712A (en) 2005-10-27
RU2268053C1 RU2268053C1 (en) 2006-01-20

Family

ID=35241431

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004113712/14A RU2268053C1 (en) 2004-05-05 2004-05-05 Method for treating hypocalcemia, osteoporosis , fractures

Country Status (2)

Country Link
RU (1) RU2268053C1 (en)
WO (1) WO2005105118A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2373185C2 (en) 2007-07-20 2009-11-20 Григорий Николаевич Коныгин Mechano-activated amorphous and amorphous-crystalline calcium salts of gluconic acid, compositions, methods of production, pharmaceutical preparations and method of treatment based on said preparations
RU2506071C1 (en) * 2012-12-04 2014-02-10 Феликс Хусаинович Камилов Calcium gluconate nanosubstance ointment for treating skin diseases related to calcium deficiency

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460803A (en) * 1989-05-24 1995-10-24 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
RU2147885C1 (en) * 1999-02-09 2000-04-27 Чернов Юрий Николаевич Method for treating the cases of osteoporosis
AU7566601A (en) * 2000-06-02 2001-12-11 Merck Patent Gmbh Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases

Also Published As

Publication number Publication date
WO2005105118A1 (en) 2005-11-10
RU2268053C1 (en) 2006-01-20

Similar Documents

Publication Publication Date Title
WO2019191092A8 (en) Compounds for treating huntington's disease
WO2018226622A8 (en) Compounds for treating huntington's disease
WO2017100726A8 (en) Methods for treating huntington's disease
UY27720A1 (en) MONOCYCLIC AROILPIRIDINONES,
NO20045037L (en) Process for the preparation of atorvastatin calcium in amorphous form
MX2011011226A (en) A novel formulation of indomethacin.
WO2005115414A3 (en) Orally-administrable compositions comprising stable amorphous calcium carbonate
MY147404A (en) Process for preparation of n-benzoyl-staurosporine
SE0501903L (en) Boron compounds useful at BNCT
CL2004001372A1 (en) MONOSODIC ALENDRONATE IN AMORPHY FORM; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT; AND ITS USE TO INHIBIT THE OSEA RESORTION IN THE TREATMENT OF FRACTURES, OSTEOPOROSIS, OSTEOARTRITIS, PAGET DISEASE, OSTEOHALISTERESIS, OS
SG114627A1 (en) Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract
WO2006041843A3 (en) Pharmaceutical dosage form comprising meloxicam
JP2008036532A5 (en)
RU2004113712A (en) METHOD FOR TREATING HYPOCALCY, OSTEOPOROSIS, FRACTURES
WO2004046134A3 (en) Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation
RU2017122035A (en) Biocompatible molded product
KR100853204B1 (en) The composition of cosmetic pack
CN204356716U (en) A kind of artificial scape stone, car stop or bench utilizing building waste to make
CN102370717A (en) Medicine for treating conjunctivitis
DE60202793D1 (en) GETTER ALLOYS AND DEVICES FOR EVAPORATING CALCIUM
RU2008116529A (en) MEDICINAL PREVENTIVE MEANS
ES2134680B1 (en) PREDICTION OF THE RESISTANCES OF THE CLINKER OR CEMENT, USING CRYSTALLOGRAPHIC FACTORS OF ITS CONSTITUENT MINERALS, DETERMINED BY DIFRACTION OF RX.
BRPI0414423A (en) pace4 inhibitors, their pharmaceutical compositions and their uses
JP2001240841A (en) Adhesive
Song et al. Usage of retro MTA for apexogenesis in immature permanent teeth

Legal Events

Date Code Title Description
QB4A Licence on use of patent

Effective date: 20080610

MM4A The patent is invalid due to non-payment of fees

Effective date: 20150506

NF4A Reinstatement of patent

Effective date: 20170110

QC41 Official registration of the termination of the licence agreement or other agreements on the disposal of an exclusive right

Free format text: LICENCE FORMERLY AGREED ON 20080610

Effective date: 20170518

MM4A The patent is invalid due to non-payment of fees

Effective date: 20180506

NF4A Reinstatement of patent

Effective date: 20190719